Top Markets
#1 Purr Purr +62.18%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +27.54%
#4 Kinetiq Kinetiq +24.51%
#5 ApeX ApeX +23.35%
#6 Fake World Assets Fake World Assets +19.18%
#7 Zora Zora +18.85%
#8 Non-Playable Coin Non-Playable Coin +18.72%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.50%
#10 OriginTrail OriginTrail +18.33%
Coin of the day
Purr Purr
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Classement en actions #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Prix de l'action
$2.72
Dernière synchronisation: 2023-10-19
Capitalisation boursière
$111.47M
Changement (1 jour)
-0.73%
Changement (1 an)
0.00%
Pays
US
Échange Talaris Therapeutics, Inc. (TALS)

Catégorie

Healthcare
Historique du rendement du dividende pour Talaris Therapeutics, Inc. (TALS)
Le rendement du dividende (TTM) de Talaris Therapeutics, Inc. (symbole boursier : TALS) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Talaris Therapeutics, Inc. (TALS) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH